- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/487 - Physical analysis of biological material of liquid biological material
Patent holdings for IPC class G01N 33/487
Total number of patents in this class: 5110
10-year publication summary
357
|
410
|
526
|
541
|
472
|
454
|
438
|
371
|
313
|
76
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
F. Hoffmann-La Roche AG | 7958 |
213 |
Roche Sequencing Solutions, Inc. | 565 |
190 |
Roche Diagnostics GmbH | 2745 |
143 |
Bayer HealthCare LLC | 1415 |
91 |
The Regents of the University of California | 18943 |
88 |
Ascensia Diabetes Care Holdings AG | 623 |
81 |
Roche Diabetes Care, Inc. | 1492 |
78 |
Oxford NanoPore Technologies Limited | 297 |
74 |
Abbott Diabetes Care Inc. | 1821 |
71 |
Oxford NanoPore Technologies plc | 207 |
63 |
President and Fellows of Harvard College | 5792 |
50 |
LifeScan Scotland Limited | 138 |
49 |
Siemens Healthcare Diagnostics Inc. | 1946 |
43 |
PHC Holdings Corporation | 701 |
42 |
International Business Machines Corporation | 60644 |
41 |
Roche Diagnostics Operations, Inc. | 1375 |
39 |
Illumina, Inc. | 2771 |
39 |
Arizona Board of Regents on behalf of Arizona State University | 2226 |
38 |
AgaMatrix, Inc. | 139 |
30 |
The Trustees of Columbia University in the City of New York | 3440 |
25 |
Other owners | 3622 |